<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Li S</submitter><funding>HHS | NIH | National Institute of General Medical Sciences</funding><funding>HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases</funding><funding>HHS | NIH | National Institute of Neurological Disorders and Stroke</funding><funding>NINDS NIH HHS</funding><funding>NIAMS NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>25104-25115</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7547246</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>117(40)</volume><pubmed_abstract>Maintaining the fidelity of nascent peptide chain (NP) synthesis is essential for proteome integrity and cellular health. Ribosome-associated quality control (RQC) serves to resolve stalled translation, during which untemplated Ala/Thr residues are added C terminally to stalled peptide, as shown during C-terminal Ala and Thr addition (CAT-tailing) in yeast. The mechanism and biological effects of CAT-tailing-like activity in metazoans remain unclear. Here we show that CAT-tailing-like modification of poly(GR), a dipeptide repeat derived from amyotrophic lateral sclerosis with frontotemporal dementia (ALS/FTD)-associated &lt;i>GGGGCC&lt;/i> (G4C2) repeat expansion in &lt;i>C9ORF72&lt;/i>, contributes to disease. We find that poly(GR) can act as a mitochondria-targeting signal, causing some poly(GR) to </pubmed_abstract><journal>Proceedings of the National Academy of Sciences of the United States of America</journal><pubmed_title>Quality-control mechanisms targeting translationally stalled and C-terminally extended poly(GR) associated with ALS/FTD.</pubmed_title><pmcid>PMC7547246</pmcid><funding_grant_id>R01GM115898</funding_grant_id><funding_grant_id>R01NS083417</funding_grant_id><funding_grant_id>R01 GM115898</funding_grant_id><funding_grant_id>R01NS084412</funding_grant_id><funding_grant_id>R01 NS084412</funding_grant_id><funding_grant_id>R01AR0748750</funding_grant_id><funding_grant_id>R01 NS083417</funding_grant_id><funding_grant_id>R01 AR074875</funding_grant_id><pubmed_authors>Wu Z</pubmed_authors><pubmed_authors>Vogel H</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Li S</pubmed_authors><pubmed_authors>Glynn S</pubmed_authors><pubmed_authors>Dong J</pubmed_authors><pubmed_authors>Tantray I</pubmed_authors><pubmed_authors>Snyder M</pubmed_authors><pubmed_authors>Chen S</pubmed_authors><pubmed_authors>Lu B</pubmed_authors></additional><is_claimable>false</is_claimable><name>Quality-control mechanisms targeting translationally stalled and C-terminally extended poly(GR) associated with ALS/FTD.</name><description>Maintaining the fidelity of nascent peptide chain (NP) synthesis is essential for proteome integrity and cellular health. Ribosome-associated quality control (RQC) serves to resolve stalled translation, during which untemplated Ala/Thr residues are added C terminally to stalled peptide, as shown during C-terminal Ala and Thr addition (CAT-tailing) in yeast. The mechanism and biological effects of CAT-tailing-like activity in metazoans remain unclear. Here we show that CAT-tailing-like modification of poly(GR), a dipeptide repeat derived from amyotrophic lateral sclerosis with frontotemporal dementia (ALS/FTD)-associated &lt;i>GGGGCC&lt;/i> (G4C2) repeat expansion in &lt;i>C9ORF72&lt;/i>, contributes to disease. We find that poly(GR) can act as a mitochondria-targeting signal, causing some poly(GR) to </description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Oct</publication><modification>2025-04-04T11:53:50.062Z</modification><creation>2025-04-04T11:53:50.062Z</creation></dates><accession>S-EPMC7547246</accession><cross_references><pubmed>32958650</pubmed><doi>10.1073/pnas.2005506117</doi></cross_references></HashMap>